• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在六个风险评分系统(CADILLAC、PAMI、TIMI、动态TIMI、兹沃勒)中,GRACE评分对ST段抬高型心肌梗死患者的长期死亡率预测显示出最佳预测价值。

GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction.

作者信息

Littnerova Simona, Kala Petr, Jarkovsky Jiri, Kubkova Lenka, Prymusova Krystyna, Kubena Petr, Tesak Martin, Toman Ondrej, Poloczek Martin, Spinar Jindrich, Dusek Ladislav, Parenica Jiri

机构信息

Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.

Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic.

出版信息

PLoS One. 2015 Apr 20;10(4):e0123215. doi: 10.1371/journal.pone.0123215. eCollection 2015.

DOI:10.1371/journal.pone.0123215
PMID:25893501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4404322/
Abstract

AIM

To compare the prognostic accuracy of six scoring models for up to three-year mortality and rates of hospitalisation due to acute decompensated heart failure (ADHF) in STEMI patients.

METHODS AND RESULTS

A total of 593 patients treated with primary PCI were evaluated. Prospective follow-up of patients was ≥3 years. Thirty-day, one-year, two-year, and three-year mortality rates were 4.0%, 7.3%, 8.9%, and 10.6%, respectively. Six risk scores--the TIMI score and derived dynamic TIMI, CADILLAC, PAMI, Zwolle, and GRACE--showed a high predictive accuracy for six- and 12-month mortality with area under the receiver operating characteristic curve (AUC) values of 0.73-0.85. The best predictive values for long-term mortality were obtained by GRACE. The next best-performing scores were CADILLAC, Zwolle, and Dynamic TIMI. All risk scores had a lower prediction accuracy for repeat hospitalisation due to ADHF, except Zwolle with the discriminatory capacity for hospitalisation up to two years (AUC, 0.80-0.83).

CONCLUSIONS

All tested models showed a high predictive value for the estimation of one-year mortality, but GRACE appears to be the most suitable for the prediction for a longer follow-up period. The tested models exhibited an ability to predict the risk of ADHF, especially the Zwolle model.

摘要

目的

比较六种评分模型对ST段抬高型心肌梗死(STEMI)患者长达三年的死亡率及急性失代偿性心力衰竭(ADHF)住院率的预测准确性。

方法与结果

共评估了593例行直接经皮冠状动脉介入治疗(PCI)的患者。对患者进行了≥3年的前瞻性随访。30天、1年、2年和3年的死亡率分别为4.0%、7.3%、8.9%和10.6%。六种风险评分——心肌梗死溶栓治疗(TIMI)评分及其衍生的动态TIMI评分、CADILLAC评分、心肌梗死溶栓治疗后心肌梗死分级(PAMI)评分、兹沃勒(Zwolle)评分和全球急性冠状动脉事件注册(GRACE)评分——对6个月和12个月死亡率显示出较高的预测准确性,受试者工作特征曲线(AUC)下面积值为0.73 - 0.85。GRACE评分对长期死亡率的预测值最佳。其次表现最佳的评分是CADILLAC评分、Zwolle评分和动态TIMI评分。除Zwolle评分对长达两年的住院具有鉴别能力(AUC,0.80 - 0.83)外,所有风险评分对因ADHF再次住院的预测准确性均较低。

结论

所有测试模型对1年死亡率的估计均显示出较高的预测价值,但GRACE评分似乎最适合较长随访期的预测。测试模型表现出预测ADHF风险的能力,尤其是Zwolle模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/4404322/994bdb819f0b/pone.0123215.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/4404322/b6b22def6c10/pone.0123215.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/4404322/276a642c2917/pone.0123215.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/4404322/7679a3ccb692/pone.0123215.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/4404322/994bdb819f0b/pone.0123215.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/4404322/b6b22def6c10/pone.0123215.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/4404322/276a642c2917/pone.0123215.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/4404322/7679a3ccb692/pone.0123215.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/4404322/994bdb819f0b/pone.0123215.g004.jpg

相似文献

1
GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction.在六个风险评分系统(CADILLAC、PAMI、TIMI、动态TIMI、兹沃勒)中,GRACE评分对ST段抬高型心肌梗死患者的长期死亡率预测显示出最佳预测价值。
PLoS One. 2015 Apr 20;10(4):e0123215. doi: 10.1371/journal.pone.0123215. eCollection 2015.
2
Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.在接受直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者中,SYNTAX 评分优于 GRACE、TIMI、ZWOLLE、CADILLAC 和 PAMI 风险评分的附加预后价值。
Int J Cardiovasc Imaging. 2013 Aug;29(6):1215-28. doi: 10.1007/s10554-013-0202-1. Epub 2013 Feb 27.
3
[Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].[改良CADILLAC、GRACE和TIMI风险评分对急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后短期死亡风险的预测价值比较]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Mar;35(3):299-304. doi: 10.3760/cma.j.cn121430-20220727-00696.
4
Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI.TIMI、PAMI、CADILLAC和GRACE风险评分对接受直接或补救性PCI的ST段抬高型急性冠状动脉综合征(STEACS)患者的预后预测价值比较。
Rev Esp Cardiol (Engl Ed). 2012 Mar;65(3):227-33. doi: 10.1016/j.recesp.2011.10.019. Epub 2012 Jan 26.
5
GRACE, TIMI, Zwolle and CADILLAC risk scores--do they predict 5-year outcomes after ST-elevation myocardial infarction treated invasively?GRACE、TIMI、Zwolle 和 CADILLAC 风险评分——它们能否预测经皮冠状动脉介入治疗后的 ST 段抬高型心肌梗死患者 5 年结局?
Int J Cardiol. 2011 Apr 1;148(1):70-5. doi: 10.1016/j.ijcard.2009.10.026. Epub 2009 Nov 18.
6
Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.四种不同风险评分对接受直接经皮冠状动脉介入治疗的ST段抬高型急性心肌梗死患者预后预测价值的比较。
Am J Cardiol. 2008 Jul 1;102(1):6-11. doi: 10.1016/j.amjcard.2008.02.088. Epub 2008 May 28.
7
Comparison of the TIMI, GRACE, PAMI and CADILLAC risk scores for prediction of long-term cardiovascular outcomes in Taiwanese diabetic patients with ST-segment elevation myocardial infarction: From the registry of the Taiwan Society of Cardiology.比较 TIMI、GRACE、PAMI 和 CADILLAC 风险评分在预测台湾 ST 段抬高型心肌梗死糖尿病患者长期心血管结局中的作用:来自台湾心脏病学会注册研究。
PLoS One. 2020 Feb 13;15(2):e0229186. doi: 10.1371/journal.pone.0229186. eCollection 2020.
8
Accuracy of dedicated risk scores in patients undergoing primary percutaneous coronary intervention in daily clinical practice.在日常临床实践中,行直接经皮冠状动脉介入治疗的患者中,专用风险评分的准确性。
Can J Cardiol. 2014 Jan;30(1):125-31. doi: 10.1016/j.cjca.2013.07.673. Epub 2013 Nov 15.
9
Comparison of the seven-year predictive value of six risk scores in acute coronary syndrome patients: GRACE, TIMI STEMI, TIMI NSTEMI, SIMPLE, ZWOLLE and BANACH.六种风险评分对急性冠脉综合征患者的七年预测价值比较:GRACE、TIMI STEMI、TIMI NSTEMI、SIMPLE、ZWOLLE和BANACH。
Kardiol Pol. 2014;72(2):155-65. doi: 10.5603/KP.a2013.0216. Epub 2013 Aug 30.
10
[Comparison on the predictive value of different scoring systems for risk of short-term death in patients with acute myocardial infarction complicating cardiogenic shock].[不同评分系统对急性心肌梗死合并心源性休克患者短期死亡风险的预测价值比较]
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Jul 24;46(7):529-535. doi: 10.3760/cma.j.issn.0253-3758.2018.07.005.

引用本文的文献

1
The predictive role of Systemic Inflammation Response Index (SIRI), Neutrophil-Lymphocyte Ratio (NLR), and Platelet-Lymphocyte Ratio (PLR) in the prognosis of acute coronary syndrome in a tertiary care hospital.三级医院中全身炎症反应指数(SIRI)、中性粒细胞与淋巴细胞比值(NLR)及血小板与淋巴细胞比值(PLR)对急性冠脉综合征预后的预测作用
Heliyon. 2024 Oct 9;10(20):e39029. doi: 10.1016/j.heliyon.2024.e39029. eCollection 2024 Oct 30.
2
UltraAIGenomics: Artificial Intelligence-Based Cardiovascular Disease Risk Assessment by Fusion of Ultrasound-Based Radiomics and Genomics Features for Preventive, Personalized and Precision Medicine: A Narrative Review.超人工智能基因组学:基于超声影像组学和基因组学特征融合的人工智能心血管疾病风险评估用于预防、个性化和精准医学:一篇综述
Rev Cardiovasc Med. 2024 May 22;25(5):184. doi: 10.31083/j.rcm2505184. eCollection 2024 May.
3

本文引用的文献

1
Dynamic TIMI risk score for STEMI.急性 ST 段抬高型心肌梗死的动态 TIMI 危险评分。
J Am Heart Assoc. 2013 Jan 29;2(1):e003269. doi: 10.1161/JAHA.112.003269.
2
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.临界血流储备分数指导下的经皮冠状动脉介入治疗与稳定型冠心病的药物治疗。
N Engl J Med. 2012 Sep 13;367(11):991-1001. doi: 10.1056/NEJMoa1205361. Epub 2012 Aug 27.
3
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.ST段抬高型急性心肌梗死患者管理的欧洲心脏病学会指南
Predicting long-term prognosis after percutaneous coronary intervention in patients with acute coronary syndromes: a prospective nested case-control analysis for county-level health services.预测急性冠脉综合征患者经皮冠状动脉介入治疗后的长期预后:一项针对县级卫生服务的前瞻性巢式病例对照分析。
Front Cardiovasc Med. 2023 Dec 4;10:1297527. doi: 10.3389/fcvm.2023.1297527. eCollection 2023.
4
Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort.连续检测高敏心肌肌钙蛋白 T、氨基末端脑钠肽前体、高敏 C 反应蛋白和生长分化因子 15 对急性冠状动脉综合征后风险评估的影响:BIOMArCS 队列研究。
Eur Heart J Acute Cardiovasc Care. 2023 Jul 7;12(7):451-461. doi: 10.1093/ehjacc/zuad042.
5
Relation of GRACE Risk Score to Coronary Lipid Core Plaques in Patients with Acute Coronary Syndrome.急性冠脉综合征患者中GRACE风险评分与冠状动脉脂质核心斑块的关系
Life (Basel). 2023 Feb 24;13(3):630. doi: 10.3390/life13030630.
6
Comparison of Different Risk Scores for Prediction of In-Hospital Mortality in STEMI Patients Treated with PPCI.接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者住院死亡率预测中不同风险评分的比较
Emerg Med Int. 2022 Dec 30;2022:5389072. doi: 10.1155/2022/5389072. eCollection 2022.
7
Measurement of left ventricular end-diastolic pressure improves the prognostic utility of the Global Registry of Acute Coronary Events score in patients with ST-segment elevation myocardial infarction.测量左心室舒张末期压力可提高ST段抬高型心肌梗死患者急性冠状动脉事件全球注册研究评分的预后预测价值。
AsiaIntervention. 2019 Jul 20;5(2):134-140. doi: 10.4244/AIJ-D-18-00051. eCollection 2019 Jul.
8
Novel scoring system based on clinical examination for prediction of in-hospital mortality in acute coronary syndrome patients: a retrospective cohort study.基于临床检查的新型评分系统对急性冠状动脉综合征患者住院死亡率的预测价值:一项回顾性队列研究。
Open Heart. 2022 Oct;9(2). doi: 10.1136/openhrt-2022-002095.
9
The Value of Different Short-Term Risk Scoring Models in Predicting Long-Term Death of Acute Myocardial Infarction.不同短期风险评分模型在预测急性心肌梗死长期死亡中的价值
J Clin Med. 2022 Aug 28;11(17):5054. doi: 10.3390/jcm11175054.
10
Systematic review and meta-analysis of prognostic models in Southeast Asian populations with acute myocardial infarction.东南亚急性心肌梗死患者预后模型的系统评价与荟萃分析。
Front Cardiovasc Med. 2022 Jul 26;9:921044. doi: 10.3389/fcvm.2022.921044. eCollection 2022.
Eur Heart J. 2012 Oct;33(20):2569-619. doi: 10.1093/eurheartj/ehs215. Epub 2012 Aug 24.
4
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.应用 SYNTAX 评分预测行直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者 1 年临床结局:STRATEGY(单次大剂量替罗非班和西罗莫司洗脱支架与阿昔单抗和裸金属支架治疗急性心肌梗死)和 MULTISTRATEGY(多中心评价单次大剂量替罗非班与阿昔单抗联合西罗莫司洗脱支架或裸金属支架治疗急性心肌梗死研究)试验的一项亚研究。
JACC Cardiovasc Interv. 2011 Jan;4(1):66-75. doi: 10.1016/j.jcin.2010.09.017.
5
A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后死亡率的预测模型:来自 Pexelizumab 在急性心肌梗死试验中的评估结果。
Circ Cardiovasc Interv. 2010 Oct;3(5):414-22. doi: 10.1161/CIRCINTERVENTIONS.109.925180. Epub 2010 Sep 21.
6
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries.欧洲ST段抬高型急性心肌梗死的再灌注治疗:30个国家的现状描述
Eur Heart J. 2010 Apr;31(8):943-57. doi: 10.1093/eurheartj/ehp492. Epub 2009 Nov 19.
7
GRACE, TIMI, Zwolle and CADILLAC risk scores--do they predict 5-year outcomes after ST-elevation myocardial infarction treated invasively?GRACE、TIMI、Zwolle 和 CADILLAC 风险评分——它们能否预测经皮冠状动脉介入治疗后的 ST 段抬高型心肌梗死患者 5 年结局?
Int J Cardiol. 2011 Apr 1;148(1):70-5. doi: 10.1016/j.ijcard.2009.10.026. Epub 2009 Nov 18.
8
Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.四种不同风险评分对接受直接经皮冠状动脉介入治疗的ST段抬高型急性心肌梗死患者预后预测价值的比较。
Am J Cardiol. 2008 Jul 1;102(1):6-11. doi: 10.1016/j.amjcard.2008.02.088. Epub 2008 May 28.
9
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE).急性冠状动脉综合征发病后六个月内死亡和心肌梗死风险的预测:前瞻性多国观察性研究(GRACE)
BMJ. 2006 Nov 25;333(7578):1091. doi: 10.1136/bmj.38985.646481.55. Epub 2006 Oct 10.
10
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.急性心肌梗死直接经皮冠状动脉介入治疗后死亡率的预测:CADILLAC风险评分
J Am Coll Cardiol. 2005 May 3;45(9):1397-405. doi: 10.1016/j.jacc.2005.01.041.